Saving Lives Through Targeted Treatments
Your support continues to fuel CURE’s urgent mission to advance precision medicine in childhood cancer treatments. This year, we directed another $2 million to the Aflac Precision Medicine Program at Children’s Healthcare of Atlanta, pushing our total investment to $14 million since 2017.
Precision medicine uses genetic sequencing to tailor treatments to each child’s unique cancer profile, offering hope where standard therapies fall short. For children like Edward, whose neuroblastoma returned after grueling treatment, precision medicine provided a lifeline. Genetic analysis led to a targeted drug that has since brought him into remission.